The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost effectiveness of immune checkpoint inhibitors in NSCLC according to PD-L1 expression.
 
Pedro Nazareth Aguiar
Honoraria - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology; Pfizer; Roche/Genentech
 
Hakaru Tadokoro
No Relationships to Disclose
 
CARMELIA MARIA NOIA BARRETO
No Relationships to Disclose
 
Ilka Lopes Santoro
No Relationships to Disclose
 
Ramon Andrade De Mello
No Relationships to Disclose
 
Hani M. Babiker
No Relationships to Disclose
 
Kiran Avancha
No Relationships to Disclose
 
Gilberto Lopes
Honoraria - AstraZeneca; Bristol-Myers Squibb; Fresenius Kabi; Janssen-Cilag; Merck Serono; Merck Sharp & Dohme; Novartis; Roche/Genentech
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly/ImClone; Pfizer
Research Funding - AstraZeneca; Eisai; Lilly/ImClone; Merck Sharp & Dohme; Pfizer
Expert Testimony - Sanofi